AQR Capital Management
NMTR

AQR Capital Management’s 9 Meters Biopharma NMTR Stock Holding History

AQR Capital Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,415
Closed -$106K – 2320
2021
Q4 		$106K Hold
5,415
– – ﹤0.01% 2145
2021
Q3 		$141K Buy
+5,415
New +$128K ﹤0.01% 2185

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management's NMTR Position: Q1 2022 in Review

AQR Capital Management sold out of 9 Meters Biopharma (NMTR) in Q1 2022, closing a stake of 5,415 shares — an estimated $106K sold.

AQR Capital Management first reported a position in NMTR in Q3 2021 and held it in 2 quarters. The position peaked at $141K in Q3 2021. 101 funds tracked by Wall St. Rank hold NMTR as of Q1 2022.

  • AQR Capital Management reported no remaining 9 Meters Biopharma position as of Q1 2022 after selling out during the quarter.
  • AQR Capital Management sold 5,415 9 Meters Biopharma shares in Q1 2022, an estimated $106K.
  • AQR Capital Management first reported a position in 9 Meters Biopharma in Q3 2021 and held it in 2 quarters.
  • AQR Capital Management's 9 Meters Biopharma position peaked at $141K in Q3 2021.
  • 101 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2022.

Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.